Of note, the human IL-2 in NOG-IL2 mice may activate tumor-resident T cells in transplanted tumor pieces and reduce the engraftment rate of PDXs in NOG-IL2 compared to NOG mice [81]. This evidence concerns the gene IL2 and neoplasm.